Global Terbinafine Hydrochloride Drug Market Size, Share, and COVID-19 Impact Analysis, By Formulation (Tablets, Creams, Sprays, Gels, and Others), By Application (Dermatophytosis, Onychomycosis, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE Feb 2026
REPORT ID SI17854
PAGES 288
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Formulation
      2. Market Attractiveness Analysis By Application
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increasing global prevalence of fungal infections
    3. Restraints
      1.  High treatment and therapy costs
    4. Opportunities
      1.  Development of new indications
    5. Challenges
      1. Presence of alternative antifungal medications
  6. Global Terbinafine Hydrochloride Drug Market Analysis and Projection, By Formulation
    1. Segment Overview
    2. Tablets
    3. Creams
    4. Sprays
    5. Gels
    6. Others
  7. Global Terbinafine Hydrochloride Drug Market Analysis and Projection, By Application
    1. Segment Overview
    2. Dermatophytosis
    3. Onychomycosis
    4. Others
  8. Global Terbinafine Hydrochloride Drug Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Terbinafine Hydrochloride Drug Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Terbinafine Hydrochloride Drug Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Alkem Laboratories Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Apotex Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Aurobindo Pharma Ltd. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Cipla Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Dr. Reddy’s Laboratories Ltd. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Glenmark Pharmaceuticals Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Hikma Pharmaceuticals PLC
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Lupin Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Sandoz International GmbH 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Sun Pharmaceutical Industries Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Teva Pharmaceutical Industries Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Torrent Pharmaceuticals Ltd. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Zydus Cadila
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  2. Global Tablets, Terbinafine Hydrochloride Drug Market, By Region, 2025-2035(USD Billion)
  3. Global Creams, Terbinafine Hydrochloride Drug Market, By Region, 2025-2035(USD Billion)
  4. Global Sprays, Terbinafine Hydrochloride Drug Market, By Region, 2025-2035(USD Billion)
  5. Global Gels, Terbinafine Hydrochloride Drug Market, By Region, 2025-2035(USD Billion)
  6. Global Others, Terbinafine Hydrochloride Drug Market, By Region, 2025-2035(USD Billion)
  7. Global Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  8. Global Dermatophytosis, Terbinafine Hydrochloride Drug Market, By Region, 2025-2035(USD Billion)
  9. Global Onychomycosis, Terbinafine Hydrochloride Drug Market, By Region, 2025-2035(USD Billion)
  10. Global Others, Terbinafine Hydrochloride Drug Market, By Region, 2025-2035(USD Billion)
  11. North America Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  12. North America Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  13. U.S.  Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  14. U.S.  Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  15. Canada Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  16. Canada Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  17. Mexico Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  18. Mexico Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  19. Europe Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  20. Europe Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  21. Germany Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  22. Germany Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  23. France Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  24. France Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  25. U.K.  Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  26. U.K.  Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  27. Italy Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  28. Italy Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  29. Spain Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  30. Spain Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  31. Asia Pacific Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  32. Asia Pacific Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  33. Japan Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  34. Japan Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  35. China Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  36. China Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  37. India Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  38. India Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  39. South America Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  40. South America Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  41. Brazil Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  42. Brazil Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  43. The Middle East and Africa Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD   Billion)
  44. The Middle East and Africa Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD   Billion)
  45. UAE Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  46. UAE Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)
  47. South Africa Terbinafine Hydrochloride Drug Market, By Formulation, 2025-2035(USD Billion)
  48. South Africa Terbinafine Hydrochloride Drug Market, By Application, 2025-2035(USD Billion)

List of Figures 

  1. Global Terbinafine Hydrochloride Drug Market Segmentation
  2. Terbinafine Hydrochloride Drug Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Terbinafine Hydrochloride Drug Market
  9. Top Winning Strategies, 2025-2035
  10. Top Winning Strategies, By Development, 2025-2035(%)
  11. Top Winning Strategies, By Company, 2025-2035
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Terbinafine Hydrochloride Drug Market
  20. Terbinafine Hydrochloride Drug Market Segmentation, By Formulation
  21. Terbinafine Hydrochloride Drug Market For Tablets, By Region, 2025-2035 ($ Billion)
  22.  Terbinafine Hydrochloride Drug Market For Creams, By Region, 2025-2035 ($ Billion)
  23. Terbinafine Hydrochloride Drug Market For Sprays, By Region, 2025-2035 ($ Billion)
  24. Terbinafine Hydrochloride Drug Market For Gels, By Region, 2025-2035 ($ Billion)
  25. Terbinafine Hydrochloride Drug Market For Others, By Region, 2025-2035 ($ Billion)
  26.  Terbinafine Hydrochloride Drug Market Segmentation, By Application
  27.  Terbinafine Hydrochloride Drug Market For Dermatophytosis, By Region, 2025-2035 ($ Billion)
  28.  Terbinafine Hydrochloride Drug Market For Onychomycosis, By Region, 2025-2035 ($ Billion)
  29. Terbinafine Hydrochloride Drug Market For Others, By Region, 2025-2035 ($ Billion)
  30. Alkem Laboratories Ltd.: Net Sales, 2025-2035 ($ Billion)
  31. Alkem Laboratories Ltd.: Revenue Share, By Segment, 2024 (%)
  32. Alkem Laboratories Ltd.: Revenue Share, By Region, 2024 (%)
  33. Apotex Inc.: Net Sales, 2025-2035 ($ Billion)
  34. Apotex Inc.: Revenue Share, By Segment, 2024 (%)
  35. Apotex Inc.: Revenue Share, By Region, 2024 (%)
  36. Aurobindo Pharma Ltd.: Net Sales, 2025-2035 ($ Billion)
  37. Aurobindo Pharma Ltd.: Revenue Share, By Segment, 2024 (%)
  38. Aurobindo Pharma Ltd.: Revenue Share, By Region, 2024 (%)
  39. Cipla Inc.: Net Sales, 2025-2035 ($ Billion)
  40. Cipla Inc.: Revenue Share, By Segment, 2024 (%)
  41. Cipla Inc.: Revenue Share, By Region, 2024 (%)
  42. Dr. Reddy’s Laboratories Ltd.: Net Sales, 2025-2035 ($ Billion)
  43. Dr. Reddy’s Laboratories Ltd.: Revenue Share, By Segment, 2024 (%)
  44. Dr. Reddy’s Laboratories Ltd.: Revenue Share, By Region, 2024 (%)
  45. Glenmark Pharmaceuticals Ltd.: Net Sales, 2025-2035 ($ Billion)
  46. Glenmark Pharmaceuticals Ltd.: Revenue Share, By Segment, 2024 (%)
  47. Glenmark Pharmaceuticals Ltd.: Revenue Share, By Region, 2024 (%)
  48. Hikma Pharmaceuticals PLC: Net Sales, 2025-2035 ($ Billion)
  49. Hikma Pharmaceuticals PLC: Revenue Share, By Segment, 2024 (%)
  50. Hikma Pharmaceuticals PLC: Revenue Share, By Region, 2024 (%)
  51. Lupin Limited: Net Sales, 2025-2035 ($ Billion)
  52. Lupin Limited: Revenue Share, By Segment, 2024 (%)
  53. Lupin Limited: Revenue Share, By Region, 2024 (%)
  54. Novartis AG.: Net Sales, 2025-2035 ($ Billion)
  55. Novartis AG.: Revenue Share, By Segment, 2024 (%)
  56. Novartis AG.: Revenue Share, By Region, 2024 (%)
  57. Sandoz International GmbH: Net Sales, 2025-2035 ($ Billion)
  58. Sandoz International GmbH: Revenue Share, By Segment, 2024 (%)
  59. Sandoz International GmbH: Revenue Share, By Region, 2024 (%)
  60. Sun Pharmaceutical Industries Ltd.: Net Sales, 2025-2035 ($ Billion)
  61. Sun Pharmaceutical Industries Ltd.: Revenue Share, By Segment, 2024 (%)
  62. Sun Pharmaceutical Industries Ltd.: Revenue Share, By Region, 2024 (%)
  63. Teva Pharmaceutical Industries Ltd.: Net Sales, 2025-2035 ($ Billion)
  64. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Segment, 2024 (%)
  65. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Region, 2024 (%)
  66. Torrent Pharmaceuticals Ltd.: Net Sales, 2025-2035 ($ Billion)
  67. Torrent Pharmaceuticals Ltd.: Revenue Share, By Segment, 2024 (%)
  68. Torrent Pharmaceuticals Ltd.: Revenue Share, By Region, 2024 (%)
  69. Zydus Cadila: Net Sales, 2025-2035 ($ Billion)
  70. Zydus Cadila: Revenue Share, By Segment, 2024 (%)
  71. Zydus Cadila: Revenue Share, By Region, 2024 (%)
  72. Others: Net Sales, 2025-2035 ($ Billion)
  73. Others: Revenue Share, By Segment, 2024 (%)
  74. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:112
Pages:288
Countries covered:17
Companies covered::18
Forecast CAGR:8.81%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies